Vero cell upstream bioprocess growth for the manufacturing of viral vectors and vaccines
The Vero cell line is taken into account probably the most used steady cell line for the manufacturing of viral vectors and vaccines. Traditionally, it’s the first cell line that was permitted by the WHO for the manufacturing of human vaccines. Complete experimental information on the manufacturing of many viruses utilizing the Vero cell line might be discovered within the literature. Nevertheless, the overwhelming majority of those processes is counting on the microcarrier know-how. Whereas this technique is established for the large-scale manufacturing of viral vaccine, it’s nonetheless fairly complicated and labor intensive.
Furthermore, scale-up stays troublesome and is proscribed by the floor space given by the carriers. To beat these and different drawbacks and to determine extra environment friendly manufacturing processes, it’s a precedence to additional develop the Vero cell platform by making use of novel bioprocess applied sciences.
Particularly in instances like the present COVID-19 pandemic, superior and scalable platform applied sciences may present extra environment friendly and cost-effective options to fulfill the worldwide vaccine demand. Herein, we evaluate the prevailing literature on Vero cell bioprocess growth for the manufacturing of viral vectors and vaccines with the goal to evaluate the latest advances in bioprocess growth.
We critically underline the necessity for additional analysis actions and describe bottlenecks to enhance the Vero cell platform by benefiting from latest developments within the cell tradition engineering subject.
Human anti-Human IL-8 mAb |
|||
MBS8576808-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Human anti-Human IL-8 mAb |
|||
MBS8576808-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Human anti-Human IL-8 mAb |
|||
MBS8576808-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Human anti-Human IL-8 mAb |
|||
MBS8576808-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
human anti-human IL-8 mAb (A5) |
|||
E4A09D07-A5A | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-8 mAb (6G) |
|||
E4A09D07-B5G | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-8 mAb (AB) |
|||
E4A09D07-C8A | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-8 mAb(N2) |
|||
E4A09D07-N2 | EnoGene | 50ug | EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
human anti-human IL-8 mAb(N8) |
|||
E4A09D07-N8 | EnoGene | 50ug | EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Anti-Human IL-8 |
|||
GWB-BIG258 | GenWay Biotech | 500ug | Ask for price |
human anti-human IL-8 mAb (1H) Humanized Antibody |
|||
MBS8574794-01mg | MyBiosource | 0.1mg | EUR 505 |
human anti-human IL-8 mAb (1H) Humanized Antibody |
|||
MBS8574794-5x01mg | MyBiosource | 5x0.1mg | EUR 2015 |
human anti-human IL-8 mAb (2H) Humanized Antibody |
|||
MBS8574795-01mg | MyBiosource | 0.1mg | EUR 505 |
human anti-human IL-8 mAb (2H) Humanized Antibody |
|||
MBS8574795-5x01mg | MyBiosource | 5x0.1mg | EUR 2015 |
Human Interleukin-8 (IL-8) Antibody |
|||
13102-05011 | AssayPro | 150 ug | EUR 175 |
Human IL-8 |
|||
90258-A | BPS Bioscience | 5 µg | EUR 130 |
Description: Recombinant human Interleukin-8 is a disulfide-linked monomer protein consisting of 78 amino acid residues, migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Interleukin-8 mature chain was expressed in E. coli. |
Human IL-8 |
|||
90258-B | BPS Bioscience | 25 µg | EUR 205 |
Description: Recombinant human Interleukin-8 is a disulfide-linked monomer protein consisting of 78 amino acid residues, migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Interleukin-8 mature chain was expressed in E. coli. |
human IL-8 |
|||
M851530020 | Tecan Benelux | 1 unit | EUR 804.84 |
human-anti-human-IL-8-mAb(1H) |
|||
E409C16-hA100 | EnoGene | Inflammation-Storm-Antibodies | EUR 276.5 |
Description: Inflammation Storm Antibodies |
human-anti-human-IL-8-mAb(2H) |
|||
E409C16-hB100 | EnoGene | Inflammation-Storm-Antibodies | EUR 276.5 |
Description: Inflammation Storm Antibodies |
Anti-Human IL-8 Antibody |
|||
101-M08 | ReliaTech | 500 µg | EUR 246.75 |
Description: Il-8 or CXCL8 was originally discovered and purified as a neutrophil chemotactic and activating factor. It was also referred to as neutrophil chemotactic factor (NCF), neutrophil activating protein (NAP), monocytederived neutrophil chemotactic factor (MDNCF), T lymphocyte chemotactic factor (TCF), granulocyte chemotactic protein (GCP) and leukocyte adhesion inhibitor (LAI). Many cell types, including monocyte/macrophages, T cells, neutrophils, fibroblasts, endothelial cells, keratinocytes, hepatocytes, chondrocytes, and various tumor cell lines, can produce CXCL8 in response to a wide variety of proinflammatory stimuli such as exposure to IL-1, TNF, LPS, and viruses. CXCL8 is a member of the alpha (CXC) subfamily of chemokines, which also includes platelet factor-4, GRO, and IP10. |
Anti-Human IL-8 Antibody |
|||
102-P38 | ReliaTech | 100 µg | EUR 245.7 |
Description: Il-8 or CXCL8 was originally discovered and purified as a neutrophil chemotactic and activating factor. It was also referred to as neutrophil chemotactic factor (NCF), neutrophil activating protein (NAP), monocytederived neutrophil chemotactic factor (MDNCF), T lymphocyte chemotactic factor (TCF), granulocyte chemotactic protein (GCP) and leukocyte adhesion inhibitor (LAI). Many cell types, including monocyte/macrophages, T cells, neutrophils, fibroblasts, endothelial cells, keratinocytes, hepatocytes, chondrocytes, and various tumor cell lines, can produce CXCL8 in response to a wide variety of proinflammatory stimuli such as exposure to IL-1, TNF, LPS, and viruses. CXCL8 is a member of the alpha (CXC) subfamily of chemokines, which also includes platelet factor-4, GRO, and IP10. |
Anti-Human IL-8 Antibody |
|||
GWB-817E77 | GenWay Biotech | 1 mL | Ask for price |
mAb anti-Human IL-8 |
|||
MBS592019-01mg | MyBiosource | 0.1mg | EUR 365 |
mAb anti-Human IL-8 |
|||
MBS592019-05mg | MyBiosource | 0.5mg | EUR 530 |
mAb anti-Human IL-8 |
|||
MBS592019-5x05mg | MyBiosource | 5x0.5mg | EUR 2140 |
mAb anti-Human IL-8 |
|||
MBS592095-01mg | MyBiosource | 0.1mg | EUR 365 |
mAb anti-Human IL-8 |
|||
MBS592095-05mg | MyBiosource | 0.5mg | EUR 530 |
mAb anti-Human IL-8 |
|||
MBS592095-5x05mg | MyBiosource | 5x0.5mg | EUR 2140 |
mAb anti-Human IL-8 |
|||
MBS592159-01mg | MyBiosource | 0.1mg | EUR 365 |
mAb anti-Human IL-8 |
|||
MBS592159-05mg | MyBiosource | 0.5mg | EUR 545 |
mAb anti-Human IL-8 |
|||
MBS592159-5x05mg | MyBiosource | 5x0.5mg | EUR 2205 |
mAb anti-Human IL-8 |
|||
MBS592219-01mg | MyBiosource | 0.1mg | EUR 365 |
mAb anti-Human IL-8 |
|||
MBS592219-05mg | MyBiosource | 0.5mg | EUR 545 |
mAb anti-Human IL-8 |
|||
MBS592219-5x05mg | MyBiosource | 5x0.5mg | EUR 2205 |
mAb anti-Human IL-8 |
|||
MBS592256-01mg | MyBiosource | 0.1mg | EUR 365 |
mAb anti-Human IL-8 |
|||
MBS592256-05mg | MyBiosource | 0.5mg | EUR 530 |
mAb anti-Human IL-8 |
|||
MBS592256-5x05mg | MyBiosource | 5x0.5mg | EUR 2140 |
Mouse Anti-Human IL-8 |
|||
MBS690051-05mg | MyBiosource | 0.5mg | EUR 525 |
Mouse Anti-Human IL-8 |
|||
MBS690051-5x05mg | MyBiosource | 5x0.5mg | EUR 2080 |
Anti-Human IL-8 (CXCL8) |
|||
MBS550689-01mg | MyBiosource | 0.1mg | EUR 260 |
Anti-Human IL-8 (CXCL8) |
|||
MBS550689-02mg | MyBiosource | 0.2mg | EUR 335 |
Anti-CXCL8 / IL-8 Reference Antibody (Genentech anti-IL-8) |
|||
E24CHA784 | EnoGene | 100 μg | EUR 225 |
Description: Available in various conjugation types. |
Human IL-8 (77aa) |
|||
MBS691916-0005mg | MyBiosource | 0.005mg | EUR 300 |
Human IL-8 (77aa) |
|||
MBS691916-0025mg | MyBiosource | 0.025mg | EUR 450 |
Human IL-8 (77aa) |
|||
MBS691916-5x0025mg | MyBiosource | 5x0.025mg | EUR 1725 |
IL-8 (72aa), Human |
|||
MBS8575167-0005mg | MyBiosource | 0.005mg | EUR 245 |
IL-8 (72aa), Human |
|||
MBS8575167-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
IL-8/CXCL8, Human |
|||
HY-P7224 | MedChemExpress | 50ug | EUR 596.4 |
Human CXCL8 (IL-8) |
|||
MBS444011-0005mg | MyBiosource | 0.005mg | EUR 150 |
Human CXCL8 (IL-8) |
|||
MBS444011-002mg | MyBiosource | 0.02mg | EUR 210 |
Human CXCL8 (IL-8) |
|||
MBS444011-005mg | MyBiosource | 0.05mg | EUR 325 |
Human CXCL8 (IL-8) |
|||
MBS444011-01mg | MyBiosource | 0.1mg | EUR 480 |
Human CXCL8 (IL-8) |
|||
MBS444011-1mg | MyBiosource | 1mg | EUR 1910 |
Human CXCL8 (IL-8) |
|||
MBS444019-0002mg | MyBiosource | 0.002mg | EUR 195 |
Human CXCL8 (IL-8) |
|||
MBS444019-001mg | MyBiosource | 0.01mg | EUR 530 |
Human CXCL8 (IL-8) |
|||
MBS444019-005mg | MyBiosource | 0.05mg | EUR 1760 |
Human CXCL8 (IL-8) |
|||
MBS444019-01mg | MyBiosource | 0.1mg | EUR 2890 |
Human IL-8 Protein |
|||
abx060803-25ug | Abbexa | 25 ug | EUR 644.4 |
Human IL-8 Protein |
|||
abx060804-25ug | Abbexa | 25 ug | EUR 644.4 |
Human IL-8 protein |
|||
PRP1022-100ug | Abbkine | 100 μg | EUR 449 |
Description: Human IL-8 protein, expressed in E. coli |
Human IL-8 protein |
|||
PRP1022-10ug | Abbkine | 10 μg | EUR 59 |
Description: Human IL-8 protein, expressed in E. coli |
Human IL-8 protein |
|||
PRP1022-1mg | Abbkine | 1 mg | EUR 2609 |
Description: Human IL-8 protein, expressed in E. coli |
Human IL-8 protein |
|||
PRP1022-50ug | Abbkine | 50 μg | EUR 249 |
Description: Human IL-8 protein, expressed in E. coli |
Human IL-8 Protein |
|||
E2RB20061PT | EnoGene | 100ul | EUR 485 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Human IL-8 protein |
|||
MBS9719016-001mg | MyBiosource | 0.01mg | EUR 115 |
Human IL-8 protein |
|||
MBS9719016-005mg | MyBiosource | 0.05mg | EUR 225 |
Human IL-8 protein |
|||
MBS9719016-01mg | MyBiosource | 0.1mg | EUR 345 |
Human IL-8 protein |
|||
MBS9719016-1mg | MyBiosource | 1mg | EUR 1745 |
Human IL-8 protein |
|||
MBS9719016-5x1mg | MyBiosource | 5x1mg | EUR 7815 |
Recombinant Human IL-8 (72a.a.)(rHu IL-8/CXCL8) |
|||
701081 | SAB | 25ul | EUR 235 |
Description: Fully biologically active when compared to standard. The ED50 as determined by a chemotaxis bioassay using human CXCR2 transfected mouse BaF3 cells is less than 2 ng/ml, corresponding to a specific activity of > 5.0 × 105 IU/mg. |
Recombinant Human IL-8 (77a.a.)(rHu IL-8/CXCL8) |
|||
701082 | SAB | 25ul | EUR 235 |
Description: Fully biologically active when compared to standard. The ED50 as determined by a chemotaxis bioassay using human CXCR2 transfected mouse BaF3 cells is less than 2 ng/ml, corresponding to a specific activity of > 5.0 × 105 IU/mg. |
Recombinant Human IL-8 (72a.a.) (rHu IL-8/CXCL8) |
|||
MBS9419956-0025mL | MyBiosource | 0.025mL | EUR 280 |
Recombinant Human IL-8 (72a.a.) (rHu IL-8/CXCL8) |
|||
MBS9419956-5x0025mL | MyBiosource | 5x0.025mL | EUR 1120 |
Recombinant Human IL-8 |
|||
6487 | Immunochemistry | 5 µg | EUR 194 |
Recombinant Human IL-8 |
|||
SJB05-01 | Amyotop | 25µg/vial | EUR 342 |
Recombinant Human IL-8 |
|||
MBS7608414-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human IL-8 |
|||
MBS7608414-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human IL-8 |
|||
MBS7608414-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human IL-8 |
|||
MBS7608414-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Recombinant Human IL-8 |
|||
MBS258218-0005mg | MyBiosource | 0.005mg | EUR 305 |
Recombinant Human IL-8 |
|||
MBS258218-5x0005mg | MyBiosource | 5x0.005mg | EUR 1210 |
Interleukin-8 (IL-8) (72a.a) Human |
|||
GWB-3997EC | GenWay Biotech | 0.025 mg | Ask for price |
Anti-Human IL-8 (257) Antibody |
|||
MBS4158332-01mg | MyBiosource | 0.1mg | EUR 685 |
Anti-Human IL-8 (257) Antibody |
|||
MBS4158332-5x01mg | MyBiosource | 5x0.1mg | EUR 2820 |
Anti-Human IL-8 (807) Antibody |
|||
MBS4158333-01mg | MyBiosource | 0.1mg | EUR 685 |
Anti-Human IL-8 (807) Antibody |
|||
MBS4158333-5x01mg | MyBiosource | 5x0.1mg | EUR 2820 |
Interleukin 8, Recombinant, Human (IL-8) |
|||
MBS650704-01mg | MyBiosource | 0.1mg | EUR 475 |
Interleukin 8, Recombinant, Human (IL-8) |
|||
MBS650704-05mg | MyBiosource | 0.5mg | EUR 775 |
Interleukin 8, Recombinant, Human (IL-8) |
|||
MBS650704-5x05mg | MyBiosource | 5x0.5mg | EUR 3330 |
Interleukin 8, Recombinant, Human (IL-8) |
|||
MBS650074-0025mg | MyBiosource | 0.025mg | EUR 665 |
Interleukin 8, Recombinant, Human (IL-8) |
|||
MBS650074-5x0025mg | MyBiosource | 5x0.025mg | EUR 2845 |
Anti-IL-8 Antibody |
|||
A00423 | BosterBio | 1 mL | EUR 1444.8 |
Description: Rabbit Polyclonal IL-8 Antibody. Validated in IP, WB and tested in Human. |
Anti-IL-8 Antibody |
|||
A2062-100 | Biovision | 100 µg | EUR 472.8 |
Anti-IL-8 Antibody |
|||
Y123169 | ABM | 100 µl | EUR 320 |
Anti-IL-8 Antibody |
|||
ER1706-67 | HUABIO | 100ul | EUR 189 |
Description: Interleukin 8 (IL-8 or chemokine (C-X-C motif) ligand 8, CXCL8) is a chemokine produced by macrophages and other cell types such as epithelial cells, airway smooth muscle cells and endothelial cells. IL-8, also known as neutrophil chemotactic factor, has two primary functions. It induces chemotaxis in target cells, primarily neutrophils but also other granulocytes, causing them to migrate toward the site of infection. IL-8 also stimulates phagocytosis once they have arrived. IL-8 is also known to be a potent promoter of angiogenesis. In target cells, IL-8 induces a series of physiological responses required for migration and phagocytosis, such as increases in intracellular Ca2+, exocytosis (e.g. histamine release), and the respiratory burst. IL-8 can be secreted by any cells with toll-like receptors that are involved in the innate immune response and has been demonstrated to be a signatory chemokine of CR2+ naive T cells, also known as recent thymic emigrants. Usually, it is the macrophages that see an antigen first, and thus are the first cells to release IL-8 to recruit other cells. Both monomer and homodimer forms of IL-8 have been reported to be potent inducers of the chemokine receptors CXCR1 and CXCR2. The homodimer is more potent, but methylation of Leu25 can block the activity of homodimers. |
Anti-IL-8 Antibody |
|||
ER1901-61 | HUABIO | 100ul | EUR 189 |
Description: IL-8, also known as neutrophil chemotactic factor, has two primary functions. It induces chemotaxis in target cells, primarily neutrophils but also other granulocytes, causing them to migrate toward the site of infection. IL-8 also stimulates phagocytosis once they have arrived. IL-8 is also known to be a potent promoter of angiogenesis. In target cells, IL-8 induces a series of physiological responses required for migration and phagocytosis, such as increases in intracellular Ca2+, exocytosis (e.g. histamine release), and the respiratory burst.IL-8 can be secreted by any cells with toll-like receptors that are involved in the innate immune response. Usually, it is the macrophages that see an antigen first, and thus are the first cells to release IL-8 to recruit other cells. Both monomer and homodimer forms of IL-8 have been reported to be potent inducers of the chemokine receptors CXCR1 and CXCR2. The homodimer is more potent, but methylation of Leu25 can block the activity of homodimers. |
Anti-IL-8 Antibody |
|||
R1511-15 | HUABIO | 100ul | EUR 189 |
Anti-IL-8 antibody |
|||
STJ98175 | St John's Laboratory | 100 µl | EUR 280.8 |
Description: Mouse monoclonal to IL-8. |
Anti-IL-8 antibody |
|||
STJ97710 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Mouse monoclonal to IL-8. |
Anti-IL-8 antibody |
|||
STJ97717 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Mouse monoclonal to IL-8. |
Anti-IL-8 antibody |
|||
STJ97720 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Mouse monoclonal to IL-8. |
Anti-IL-8 Antibody |
|||
MBS821263-003mL | MyBiosource | 0.03mL | EUR 185 |
Anti-IL-8 Antibody |
|||
MBS821263-01mL | MyBiosource | 0.1mL | EUR 255 |
Anti-IL-8 Antibody |
|||
MBS821263-02mL | MyBiosource | 0.2mL | EUR 335 |
Anti-IL-8 Antibody |
|||
MBS821263-5x02mL | MyBiosource | 5x0.2mL | EUR 1420 |
Anti-IL-8 antibody |
|||
MBS175692-01mg | MyBiosource | 0.1mg | EUR 450 |
Anti-IL-8 antibody |
|||
MBS175692-5x01mg | MyBiosource | 5x0.1mg | EUR 1870 |
Anti-IL-8 Antibody |
|||
MBS415375-01mL | MyBiosource | 0.1mL | EUR 440 |
Anti-IL-8 Antibody |
|||
MBS415375-5x01mL | MyBiosource | 5x0.1mL | EUR 1720 |
human DIAplex Human Inflammation - IL-8, IL-17a, |
|||
M880130004 | Tecan Benelux | 1 unit | EUR 650.27 |
mAb mouse anti-human IL-8 |
|||
CT264 | U-CyTech | 0.5 mg | EUR 312 |
Environment friendly Induction of Cytotoxic T Cells by Viral Vector Vaccination Requires STING-Dependent DC Capabilities
Modified Vaccinia virus Ankara (MVA) is an attenuated pressure of vaccinia virus and at the moment underneath investigation as a promising vaccine vector in opposition to infectious ailments and most cancers. MVA acquired mutations in host vary and immunomodulatory genes, rendering the virus poor for replication in most mammalian cells. MVA has a excessive security profile and induces strong immune responses. Nevertheless, the function of innate immune triggers for the induction of cytotoxic T cell responses after vaccination is incompletely understood.
Stimulator of interferon genes (STING) is an adaptor protein which integrates signaling downstream of a number of DNA sensors and subsequently mediates the induction of kind I interferons and different cytokines or chemokines in response to numerous dsDNA viruses. Because the kind I interferon response was fully STING-dependent throughout MVA an infection, we studied the impact of STING on main and secondary cytotoxic T cell responses and reminiscence T cell formation after MVA vaccination in STING KO mice.
Furthermore, we analyzed the impression of STING on the maturation of bone marrow-derived dendritic cells (BMDCs) and their performance as antigen presenting cells for cytotoxic T cells throughout MVA an infection in vitro. Our outcomes present that STING has an impression on the antigen processing and presentation capability of conventionel DCs and performed an important function for DC maturation and kind I interferon manufacturing. Importantly, STING was required for the induction of environment friendly cytotoxic T cell responses in vivo, since we noticed considerably decreased short-lived effector and effector reminiscence T cell responses after priming in STING KO mice.
These findings point out that STING most likely integrates innate immune signaling downstream of various DNA sensors in DCs and shapes the cytotoxic T cell response through the DC maturation phenotype which strongly depends upon kind I interferons on this an infection mannequin. Understanding the detailed capabilities of innate immune triggers throughout MVA an infection will contribute to the optimized design of MVA-based vaccines.
Number of chromatographic strategies for the purification of cell culture-derived Orf virus for its software as a vaccine or viral vector
Lately, the Orf virus has change into a promising software for protecting recombinant vaccines and oncolytic remedy. Nevertheless, appropriate strategies for an Orf virus manufacturing, together with up- and downstream, are very restricted. The offered examine focuses on downstream processing, describing the analysis of various chromatographic unit operations.
On this context, ion exchange-, pseudo-affinity- and steric exclusion chromatography have been employed for the purification of the cell culture-derived Orf virus, aiming at a most in virus restoration and contaminant depletion. Probably the most promising chromatographic strategies for capturing the virus particles have been the steric exclusion- or salt-tolerant anion change membrane chromatography, recovering 84% and 86% of the infectious virus.
Combining the steric exclusion chromatography with a subsequent CaptoTM Core 700 resin or hydrophobic interplay membrane chromatography as a secondary chromatographic step, total virus recoveries of as much as 76% have been achieved. Moreover, a whole mobile protein removing and a bunch cell DNA depletion of as much as 82% was attainable for the steric exclusion membranes and the CaptoTM Core 700 mixture. The examine reveals a spread of attainable unit operations fitted to the chromatographic purification of the cell culture-derived Orf virus, relying on the meant software, i.e. a human or veterinary use, and the required purity.
Mouse Anti-Human LEC |
|||
MBS690207-5x05mg | MyBiosource | 5x0.5mg | EUR 2080 |
Anti-Human LEC (CCL16) |
|||
MBS550695-01mg | MyBiosource | 0.1mg | EUR 260 |
Anti-Human LEC (CCL16) |
|||
MBS550695-02mg | MyBiosource | 0.2mg | EUR 335 |
Recombinant Human LEC |
|||
MBS7608806-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human LEC |
|||
MBS7608806-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human LEC |
|||
MBS7608806-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human LEC |
|||
MBS7608806-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Recombinant Human LEC (CCL16) |
|||
Z100325 | ABM | 25 µg | EUR 235 |
Description: CCL16 is a CC chemokine that specifically attracts lymphocytes, dendritic cells, and monocytes; increases their adhesive properties and has myelosuppressive activity. It is constitutively expressed in liver and is increased by interleukin 10 (IL-10) in activated monocytes. CCL16 is present in human plasma suggesting that it may be active outside hepatic tissue. CCR1, CCR2, CCR5, and CCR8 are the functional receptors of this chemokine. |
Recombinant Human LEC (CCL16) |
|||
Z100329 | ABM | 1.0 mg | EUR 3900 |
Description: CCL16 is a CC chemokine that specifically attracts lymphocytes, dendritic cells, and monocytes; increases their adhesive properties and has myelosuppressive activity. It is constitutively expressed in liver and is increased by interleukin 10 (IL-10) in activated monocytes. CCL16 is present in human plasma suggesting that it may be active outside hepatic tissue. CCR1, CCR2, CCR5, and CCR8 are the functional receptors of this chemokine. |
Recombinant Human LEC (CCL16) |
|||
MBS4159662-0025mg | MyBiosource | 0.025mg | EUR 385 |
Recombinant Human LEC (CCL16) |
|||
MBS4159662-1mg | MyBiosource | 1(mg) | EUR 4600 |
Recombinant Human LEC (CCL16) |
|||
MBS4159662-5x1mg | MyBiosource | 5x1mg | EUR 20445 |
Human LEC (CCL16) Recombinant |
|||
MBS553045-0005mg | MyBiosource | 0.005mg | EUR 165 |
Human LEC (CCL16) Recombinant |
|||
MBS553045-0025mg | MyBiosource | 0.025mg | EUR 245 |
Anti-Human LEC/NCC-4 Antibody |
|||
102-P51G | ReliaTech | 100 µg | EUR 245.7 |
Description: LEC or NCC-4 is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
Human LEC/CCL16 Antibody Pair Set |
|||
ABPR-ZB293 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
Description: Quantitative determination of Human LEC/CCL16 |
Anti-Human LEC Goat Polyclonal Antibody |
|||
TA328365 | Origene Technologies GmbH | 100 µg | Ask for price |
Human LEC/NCC-4 (CCL16) |
|||
MBS692056-0005mg | MyBiosource | 0.005mg | EUR 300 |
Human LEC/NCC-4 (CCL16) |
|||
MBS692056-002mg | MyBiosource | 0.02mg | EUR 450 |
Human LEC/NCC-4 (CCL16) |
|||
MBS692056-5x002mg | MyBiosource | 5x0.02mg | EUR 1725 |
Recombinant Human LEC (CCL16) Protein |
|||
PROTO15467-1 | BosterBio | 20ug | EUR 380.4 |
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
Recombinant Human LEC/CCL16 protein |
|||
CD01396-5ug | Jiaxing Korain Biotech Ltd (BT Labs) | 5ug | EUR 176 |
Description: Human CCL16, also called Liver-expressed chemokine (LEC), Monotactin-1 (MTN-1), IL-10-inducible chemokine and so on, is expressed by the CCL16 gene located on the chromosome 17 in humans. The gene encodes a 120 a.a. residue precursor protein with a 23 a.a. residue predicted signal peptide that is cleaved to generate a 97 a.a. residue mature protein. The protein is secreted by the liver, thymus, spleen cells and showing chemotactic activity for lymphocytes and monocytes but it is distantly related to other CC chemokines, exhibiting less than 30 % sequence identity. CCL16 is highly induced by IL-10, IFN-γ and bacterial lipopolysaccharide in monmcytes and signal through CCR1, CCR2, CCR5, and CCR8. |
LEC/NCC-4 Human Recombinant |
|||
rAP-0241 | Angio Proteomie | Inquiry | Ask for price |
Human LEC Recombinant Protein Lyophilized |
|||
IHULECRLY5UG | Innovative research | each | EUR 341 |
Description: Human LEC Recombinant Protein Lyophilized |
Human LEC Recombinant Protein Lyophilized |
|||
MBS8432637-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Biotinylated Anti-Human LEC Goat Polyclonal Antibody |
|||
TA328364 | Origene Technologies GmbH | 50 µg | Ask for price |
LEC antibody |
|||
10R-L115A | Fitzgerald | 500 ug | EUR 240 |
Description: Mouse monoclonal LEC antibody |
LEC antibody |
|||
70R-LG003 | Fitzgerald | 50 ug | EUR 312 |
Description: Affinity purified Goat polyclonal LEC antibody |
LEC antibody |
|||
MBS532318-05mg | MyBiosource | 0.5mg | EUR 370 |
LEC antibody |
|||
MBS532318-5x05mg | MyBiosource | 5x0.5mg | EUR 1525 |
LEC antibody |
|||
MBS535708-005mg | MyBiosource | 0.05mg | EUR 465 |
LEC antibody |
|||
MBS535708-5x005mg | MyBiosource | 5x0.05mg | EUR 1945 |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
7-01792 | CHI Scientific | 5µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
7-01793 | CHI Scientific | 20µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
7-01794 | CHI Scientific | 1mg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
HECCP-1601 | Cyagen | 5ug | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
MBS143272-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
MBS143272-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
MBS143272-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
MBS143272-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-14] |
|||
LEC-14-100ug | Biologicals | 100 ug | EUR 141.79 |
Description: Identify and measure human LEC. Marker for inflammatory processes. |
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-14] |
|||
LEC-14-1mg | Biologicals | 1 mg | EUR 897.6 |
Description: Identify and measure human LEC. Marker for inflammatory processes. |
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-14] |
|||
LEC-14-500ug | Biologicals | 500 ug | EUR 479.6 |
Description: Identify and measure human LEC. Marker for inflammatory processes. |
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-57] |
|||
LEC-57-100ug | Biologicals | 100 ug | EUR 141.79 |
Description: Identify and measure human LEC. Marker for inflammatory processes. |
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-57] |
|||
LEC-57-1mg | Biologicals | 1 mg | EUR 897.6 |
Description: Identify and measure human LEC. Marker for inflammatory processes. |
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-57] |
|||
LEC-57-500ug | Biologicals | 500 ug | EUR 479.6 |
Description: Identify and measure human LEC. Marker for inflammatory processes. |
LEC/CCL16 Matched ELISA Antibody Pair Set, Human |
|||
MBS8118261-15Plates | MyBiosource | 15Plates | EUR 600 |
LEC/CCL16 Matched ELISA Antibody Pair Set, Human |
|||
MBS8118261-5Plates | MyBiosource | 5Plates | EUR 345 |
LEC/CCL16 Matched ELISA Antibody Pair Set, Human |
|||
MBS8118261-5x15Plates | MyBiosource | 5x15Plates | EUR 2755 |
HCC-4, LEC, NCC-4, CCL16, human |
|||
RC315-27 | Bio Basic | 5ug | EUR 125.26 |
Human LEC/NCC-4 (CCL16) Recombinant Protein |
|||
100-060 | ReliaTech | 20 µg | EUR 196.35 |
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
Human LEC/NCC-4 (CCL16) Recombinant Protein |
|||
100-060S | ReliaTech | 5 µg | EUR 92.4 |
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
LEC (CCL16) (NM_004590) Human Over-expression Lysate |
|||
LS006360 | BosterBio | 100ug | EUR 628 |
Description: Transient overexpression lysate of chemokine (C-C motif) ligand 16 (CCL16) |
CCL16 LEC/NCC-4 Human Recombinant Protein |
|||
PROTO15467 | BosterBio | Regular: 20ug | EUR 380.4 |
Description: CCL16 Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 97 amino acids and having a molecular mass of 11.2 kDa. ;The CCL16 is purified by proprietary chromatographic techniques. |
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
MBS8120314-005mg | MyBiosource | 0.05mg | EUR 340 |
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
MBS8120314-1mg | MyBiosource | 1mg | EUR 2530 |
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
MBS8120314-5x1mg | MyBiosource | 5x1mg | EUR 11240 |
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
MBS8120315-005mg | MyBiosource | 0.05mg | EUR 340 |
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
MBS8120315-5x005mg | MyBiosource | 5x0.05mg | EUR 1380 |
LEC, NCC-4, Human (Liver-Expressed Chemokine) |
|||
MBS635010-0005mg | MyBiosource | 0.005mg | EUR 340 |
LEC, NCC-4, Human (Liver-Expressed Chemokine) |
|||
MBS635010-002mg | MyBiosource | 0.02mg | EUR 490 |
LEC, NCC-4, Human (Liver-Expressed Chemokine) |
|||
MBS635010-5x002mg | MyBiosource | 5x0.02mg | EUR 2055 |
LEC Chemokine(LEC66) Antibody |
|||
BNC040066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC040066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC040067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC040067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC810066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC810066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC810067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC810067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC940066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC940066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC940067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC940067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC880066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC880066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC880067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC880067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC430066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC430066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC430067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC430067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC050066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC050066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC050067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC050067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC470066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC470066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC470067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC470067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC400066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC400066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC400067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC400067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC550066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC550066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC550067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC550067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC610066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC610066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC610067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC610067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC800066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC800066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC800067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC800067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC700066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC700066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC700067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC700067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC680066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC680066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC680067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC680067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCP0066-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC66), PerCP conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCP0067-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC67), PerCP conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCR0066-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC66), RPE conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCR0067-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC67), RPE conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNUB0066-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Concentration: 0.2mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNUB0066-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against LEC Chemokine(LEC66), Concentration: 0.2mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNUB0067-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Concentration: 0.2mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNUB0067-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against LEC Chemokine(LEC67), Concentration: 0.2mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCA0066-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC66), APC conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCA0067-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC67), APC conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCAP0066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCAP0066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCAP0067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCAP0067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCB0066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Biotin conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCB0066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Biotin conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCB0067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Biotin conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCB0067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Biotin conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNUM0066-50 | Biotium | 50uL | EUR 474 |
Description: Primary antibody against LEC Chemokine(LEC66), 1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNUM0067-50 | Biotium | 50uL | EUR 474 |
Description: Primary antibody against LEC Chemokine(LEC67), 1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCH0066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCH0066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCH0067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCH0067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
LEC protein |
|||
30R-AL013 | Fitzgerald | 20 ug | EUR 312 |
Description: Purified recombinant Human LEC protein |
LEC protein |
|||
MBS539381-002mg | MyBiosource | 0.02mg | EUR 465 |
LEC protein |
|||
MBS539381-5x002mg | MyBiosource | 5x0.02mg | EUR 1945 |
Mouse Anti-Human LEC/CCL16 monoclonal antibody, clone NN13 |
|||
CABT-ZB713 | Creative Diagnostics | 50 μl | EUR 456 |
Description: Mouse |
Rabbit anti-Caenorhabditis elegans lec-8 Polyclonal Antibody |
|||
MBS7146069-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-Caenorhabditis elegans lec-1 Polyclonal Antibody |
|||
MBS7155373-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-Caenorhabditis elegans lec-7 Polyclonal Antibody |
|||
MBS7187540-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-Caenorhabditis elegans lec-3 Polyclonal Antibody |
|||
MBS7187661-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Caenorhabditis elegans Probable galaptin lec-7 (lec-7) |
|||
MBS1389340-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1100 |
Recombinant Caenorhabditis elegans Probable galaptin lec-7 (lec-7) |
|||
MBS1389340-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 695 |
Recombinant Caenorhabditis elegans Probable galaptin lec-7 (lec-7) |
|||
MBS1389340-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 855 |
Recombinant Caenorhabditis elegans Probable galaptin lec-7 (lec-7) |
|||
MBS1389340-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 810 |
Recombinant Caenorhabditis elegans Probable galaptin lec-7 (lec-7) |
|||
MBS1389340-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 995 |
CCL16/LEC Polyclonal Antibody |
|||
MBS9237600-01mL | MyBiosource | 0.1mL | EUR 415 |
CCL16/LEC Polyclonal Antibody |
|||
MBS9237600-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
Anti-LEC/CCL16/HCC4 antibody |
|||
STJ16100997 | St John's Laboratory | 100 µg | EUR 424.8 |
LEC Recombinant Protein |
|||
40-396-0005mg | ProSci | 0.005 mg | EUR 311.1 |
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
LEC Recombinant Protein |
|||
40-396-002mg | ProSci | 0.02 mg | EUR 437.1 |
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
LEC Antibody / HCC-4 / CCL16 |
|||
RQ4655 | NSJ Bioreagents | 100ug | EUR 356.15 |
Description: Chemokine (C-C motif) ligand 16 (CCL16) is a small cytokine belonging to the CC chemokine family that is known under several pseudonyms, including Liver-expressed chemokine (LEC) and Monotactin-1 (MTN-1). This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for lymphocytes and monocytes but not for neutrophils. This cytokine also shows a potent myelosuppressive activity and suppresses proliferation of myeloid progenitor cells. The expression of this gene is upregulated by IL-10. |
Refrigerator LEC 130ltr LR111 |
|||
REF1990 | Scientific Laboratory Supplies | EACH | EUR 451.44 |
Anti-LEC/CCL16 Antibody, Mouse Monoclonal |
|||
MBS8102991-01mL | MyBiosource | 0.1mL | EUR 300 |
Anti-LEC/CCL16 Antibody, Mouse Monoclonal |
|||
MBS8102991-5x01mL | MyBiosource | 5x0.1mL | EUR 1200 |
Anti-LEC/CCL16 Antibody, Mouse Monoclonal |
|||
MBS8102992-01mL | MyBiosource | 0.1mL | EUR 300 |
Anti-LEC/CCL16 Antibody, Mouse Monoclonal |
|||
MBS8102992-5x01mL | MyBiosource | 5x0.1mL | EUR 1200 |
Freezer LEC 85ltr ISU111 |
|||
REF1992 | Scientific Laboratory Supplies | EACH | EUR 451.44 |
Anti-LEC/CCL16 Antibody, Rabbit Polyclonal |
|||
MBS8102994-01mL | MyBiosource | 0.1mL | EUR 300 |
Anti-LEC/CCL16 Antibody, Rabbit Polyclonal |
|||
MBS8102994-5x01mL | MyBiosource | 5x0.1mL | EUR 1200 |
Anti-LEC/CCL16 Antibody, Rabbit Polyclonal |
|||
MBS8102995-01mL | MyBiosource | 0.1mL | EUR 300 |
Anti-LEC/CCL16 Antibody, Rabbit Polyclonal |
|||
MBS8102995-5x01mL | MyBiosource | 5x0.1mL | EUR 1200 |
Recombinant Caenorhabditis elegans 32 kDa beta-galactoside-binding lectin lec-3 (lec-3) |
|||
MBS1325733-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1175 |
Recombinant Caenorhabditis elegans 32 kDa beta-galactoside-binding lectin lec-3 (lec-3) |
|||
MBS1325733-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 820 |
Recombinant Caenorhabditis elegans 32 kDa beta-galactoside-binding lectin lec-3 (lec-3) |
|||
MBS1325733-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 965 |
Recombinant Caenorhabditis elegans 32 kDa beta-galactoside-binding lectin lec-3 (lec-3) |
|||
MBS1325733-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 985 |
Recombinant Caenorhabditis elegans 32 kDa beta-galactoside-binding lectin lec-3 (lec-3) |
|||
MBS1325733-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1130 |
Rabbit anti-Arabidopsis thaliana (Mouse-ear cress) LEC Polyclonal Antibody |
|||
MBS9016168-INQUIRE | MyBiosource | INQUIRE | Ask for price |
LEC (CCL16) goat polyclonal antibody, Biotin |
|||
PP1090B1 | Origene Technologies GmbH | 25 µg | Ask for price |
LEC (CCL16) goat polyclonal antibody, Biotin |
|||
PP1090B2 | Origene Technologies GmbH | 50 µg | Ask for price |